ASEP Share Price Performance
Recent ASEP News & Updates
No updates
ASEP Medical Holdings Inc. Key Details
Last Reported Earnings
Sep 30, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.42
- Gross Margin
- 100.00%
- Net Profit Margin
- -1,900.29%
- Debt/Equity Ratio
- 1.5%
ASEP Medical Holdings Inc. Competitors
About ASEP
- Founded
- 2021
- Employees
- 6
- CEO
- WebsiteView website
ASEP Medical Holdings Inc., together with its subsidiaries, focuses on developing diagnostic and therapeutic solutions for the treatment of sepsis. It offers peptide technology for therapeutic applications, including bacterial biofilm infections, anti-inflammatories, anti-infective immune-modulators, and vaccine adjuvants; diagnostic kits for predicting the onset of severe sepsis and organ failure; and coatings for medical devices. The company was formerly known as Trenchant Life Sciences Investment Corp. and changed its name to ASEP Medical Holdings Inc. in November 2021. ASEP Medical Holdings Inc. was incorporated in 2021 and is headquartered in Victoria, Canada.
Canadian Market Performance
- 7 Days: 0.9%
- 3 Months: 11.7%
- 1 Year: 17.4%
- Year to Date: 10.1%
The Consumer Staples sector gained 3.6% while the market remained flat over the last week. Meanwhile, the market is actually up 17% over the past year. Earnings are forecast to grow by 12% annually. Market details ›
The tide is turning for UK & European markets. Index ETFs won’t cut it since sector spreads are massive. Picking the right companies matters now more than ever.
Continue readingLast Week
